[What should be considered in the administration of cholesterol synthesis enzyme inhibitors? Interaction and adverse effect potentials of statins].
Ritter
Christoph A
CA
Insitut für Pharmakologie, Peter Holtz Center of Pharmacology and Experimental Therapeutics, Klinikum, Ernst-Moritz-Arndt-Universität, Friedrich-Loeffler-Str. 23D, 17487 Greifswald. kroemer@uni-greifswald.de
Kroemer
Heyo K
HK
D000818:Animals; D004347:Drug Interactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D008099:Liver / Q000378:metabolism
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors